Endocrine oncology

A Thyroid-Cancer-Specific Utility Index: Development and Valuation of the Thyroid Cancer Quality of Life Index

ThyroidPublished Cross-sectional study

Authors' conclusion

TCQOLI is a psychometrically robust, thyroid-cancer-specific, preference-based measure with patient-anchored valuation, suitable for health-economic evaluations. This concise index supports comparative-effectiveness research in thyroid cancer and informs resource allocation across clinical and policy settings.

Study context

Population
Adults with thyroid cancer3 phases
Outcome
Agreement of 9-domain additive multiattribute utility theory index with direct VAS
Methodological detailsmulticenter, multiphase, mixed-method
  • Multicenter
  • Multiphase
  • Mixed-method

Main finding

As reported in the abstract

Pearson r with direct visual analog scales (VAS)

≈ 0.74-0.75

Mean absolute error (MAE)/overall standard deviation (OSD) after standard gamble (SG) mapping

0.045/0.095

Intraclass correlation (ICC) (good to excellent)

0.74

Observational data: associations, not effects.

Further findings

Instrument development and psychometrics

Candidate domains finalized; primary instrument uses 9 domains (reproduction concern excluded)
10
Instrument-level ceiling effect
3.8%
Floor effect
none
Confirmatory factor analysis (CFA) supported a general health-related quality of life (HRQoL) factor plus a voice/swallow factor with acceptable composite reliability and model fit

Phase sample sizes

Cognitive interviews
50
Psychometric survey
163
Valuation sample
103

Original publication

A Thyroid-Cancer-Specific Utility Index: Development and Valuation of the Thyroid Cancer Quality of Life Index. Thyroid. Published 24 February 2026. doi:10.1177/10507256261425624

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.